Invesco India Small Cap Fund - Direct Plan - Growth
code 145137 Small Cap Fund direct plan · growth NAVs 2018-11-02 to 2026-11-09
Growth of ₹10,000
From 2018-11-02. Scroll or drag to zoom.
Drawdown
Rolling 3-year CAGR
Returns
| period | fund | from → to |
|---|---|---|
| 1M | 5.64% | 2026-10-09 → 2026-11-09 |
| 3M | 1.68% | 2026-08-07 → 2026-11-09 |
| 6M | 12.46% | 2026-05-08 → 2026-11-09 |
| 1Y | 16.48% | 2025-11-07 → 2026-11-09 |
| 3Y | 21.21% | 2023-11-09 → 2026-11-09 |
| 5Y | 18.85% | 2021-11-09 → 2026-11-09 |
| 7Y | 26.40% | 2019-11-08 → 2026-11-09 |
| 10Y | - | |
| since inception | 23.55% | 2018-11-02 → 2026-11-09 |
Absolute under 1 year, CAGR from 1 year.
Calendar years
| year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| fund | 5.57% | 26.84% | 64.99% | 0.91% | 46.10% | 39.37% | -1.57% |
Rolling returns
| length | periods | average | median | worst | best | % positive |
|---|---|---|---|---|---|---|
| 1 year | 1,732 | 27.78% | 18.12% | -25.53% | 105.64% | 92% |
| 3 years | 1,236 | 28.85% | 28.24% | 19.05% | 41.60% | 100% |
| 5 years | 743 | 28.88% | 29.13% | 17.31% | 39.25% | 100% |
Risk and risk-adjusted return
| 3 years 2023-11 – 2026-10 | 5 years 2021-11 – 2026-10 | |
|---|---|---|
| CAGR | 20.26% | 18.13% |
| volatility | 20.03% | 17.85% |
| max drawdown | -23.41% | -23.41% |
| downside deviation | 12.75% | 11.19% |
| Sharpe ratio | 0.73 | 0.71 |
| Sortino ratio | 1.15 | 1.13 |
| Calmar ratio | 0.87 | - |
Category: Small Cap Fund
Overall ★★★★★ (3y ★★★★★ · 5y ★★★★★ · 10y -) · as of 2026-10 · 95 months of history
| percentile rank (1 = best) | 3 years of 24 funds | 5 years of 21 funds |
|---|---|---|
| return | 9th | 5th |
| volatility | 44th | 45th |
| Sharpe | 9th | 1st |
| Sortino | 9th | 10th |
| worst fall | 35th | 35th |
| risk-adjusted return (MRAR) | 9th | 1st |
Ratings: Morningstar method. Differences: risk-free rate: RBI 91-day T-bill (Morningstar uses FBIL MIBOR Overnight for rupee funds); peer groups: SEBI-category groups (D13), not Morningstar Categories; no analyst rating suspensions.